GoodRx Holdings, Inc.

GoodRx Holdings, Inc. (NASDAQ: GDRX) operates as a leading consumer-focused digital healthcare platform in the United States, accessible through www.goodrx.com. The company's mission centers on helping Americans save time and money when filling medications by removing friction and inefficiencies from the healthcare system.

The platform processes over 420 billion pricing data points daily, aggregating prescription pricing information from pharmacy benefit managers, pharmacies, pharmaceutical manufacturers, and patient assistance programs. GoodRx enables consumers to access dynamic, geographically relevant prescription pricing and negotiated prices through GoodRx codes that can be presented at nearly every retail pharmacy in the United States. The company's prescription transactions offering represents its core business, complemented by subscription offerings including Gold, RxSmartSaver+, and condition-specific subscription programs that bundle clinician visits, prescriptions, and delivery services.

Beyond prescriptions, GoodRx operates a pharma direct offering that partners with pharmaceutical manufacturers to integrate affordability solutions such as co-pay cards, patient assistance programs, and consumer direct pricing into its platform. The company also provides telehealth services through GoodRx Care and educational content through GoodRx Health, which offers research-backed health information to consumers.

GoodRx's value proposition extends across multiple healthcare ecosystem stakeholders. Consumers benefit from free access to lower prescription prices and comprehensive healthcare solutions. Healthcare providers gain tools to improve patient outcomes and medication adherence. Pharmacy benefit managers, pharmacies, and pharmaceutical manufacturers utilize the platform to reach consumers and drive incremental volume and sales.

The company's technology infrastructure includes proprietary pricing engines, constant data refresh capabilities, artificial intelligence and machine learning algorithms, and cloud-native scalable architecture. GoodRx maintains SOC2 certification and implements security procedures informed by industry-standard frameworks.

The company estimates its total addressable market between $600 billion and $710 billion, encompassing a $581 billion to $691 billion prescription opportunity and a $19 billion pharma direct opportunity. GoodRx generates revenue through percentage-based or fixed payments from pharmacy benefit managers, fixed or variable fees from partner pharmacies, subscription fees from consumers, and advertising and integration fees from pharmaceutical manufacturers.